| NRGSX | PCSMX | NRGSX / PCSMX | |
| Total Expense Ratio | 0.74 | 0.87 | 85% |
| Annual Report Gross Expense Ratio | 0.74 | 0.90 | 82% |
| Fund Existence | 13 years | 11 years | - |
| Gain YTD | -4.162 | 11.678 | -36% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.43B | 2.08B | 406% |
| Annual Yield % from dividends | 0.07 | 0.54 | 12% |
| Returns for 1 year | -13.93 | -2.00 | 698% |
| Returns for 3 years | -1.73 | 29.53 | -6% |
| Returns for 5 years | -6.57 | -1.59 | 412% |
| Returns for 10 years | 10.77 | 40.16 | 27% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNGLX | 81.36 | 0.73 | +0.91% |
| Janus Henderson Global Life Sciences D | |||
| IINCX | 25.73 | 0.16 | +0.63% |
| Macquarie International Core Eq R6 | |||
| QDISX | 21.07 | 0.07 | +0.33% |
| FI Instl Group Stock for Ret Plns | |||
| VCAAX | 12.88 | -0.01 | -0.08% |
| VALIC Company I Asset Allocation | |||
| SCATX | 65.52 | -0.19 | -0.29% |
| Virtus Zevenbergen Innovative Gr Stk I | |||